Q: With the large net cash position on MCR’s balance sheet, big Q4, and nice back log for 2019, is this a good price to buy MCR? I know the business is cyclical but things appear to be lining up and it’s very hard to find potential value + growth that MCR appears to offer right now. Thanks
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Looks like a buyout. Would you sell now or do you think there is a potential for a higher bid? Thank you.
Q: PSD has just took on some debit with a buyout. I have held this stock for 3 years and down on it still. I would appreciate your option on upside or will it be a take over candidate.
Q: DCM reported this week. The market responded negatively although the numbers seemed reasonably good. Your thoughts.
Thanks.
Philip
Thanks.
Philip
Q: was thinking of buying a few shares of this company . would appreciate your opinion on this company. thank you fred.
Q: Hi 5i - what should we take away from the recent approx 90% exercise of warrants for this company? Is this good news - or neutral news in your view?
Q: Near end of Feb,it formed partnership with Rinco.Please comment on this & VCM.I have a small interest for some time.If U think it is time to move on.please suggest 1 or 2 companies Thanks for uusual great services & views
Q: Please comment on their Q4, including how it stacked up against forecasts.
Q: If you were interviewing the CEO from this company, what questions would you ask? Any comments in general on the US pot sector? Unique competitive advantages of this company?
Q: Any idea of what is causing the weakness in PTA as of late and especially today? Thanks
Q: New associations & acceptance by certain US companies as well as a TSX principal listing should open the door a little wider for this growing junior. What's your opinion!
Thank you.
Thank you.
Q: For a 5 year hold,would you please rank these companies on a risk/reward criteria.Thanks.
Q: CSO now has a few quarters under its belt as a strictly metallurgical coal producer - is it looking like a survivor in its field (metrics improving?)?
Also, on 13-March near the end of the day, 10x the average volume was traded in one minute and at about 9% above the intraday high to that point. Any information on that trade, or insight?
Also, on 13-March near the end of the day, 10x the average volume was traded in one minute and at about 9% above the intraday high to that point. Any information on that trade, or insight?
Q: Opinion of value after last report, and responding share price movement?
Q: What is the outlook for CRMD ? I am 21% under water. Hold, sell, buy more ?Thank you for the good work.
Jacques
Jacques
Q: Peter, I have held Kew for a period of six weeks or so and have seen the stock climb by 25% or so in that time. TD Bank has an action list buy on the stock and a very high one year price target. Is this one of those winners that you would hold on to?
Q: Can you comment on why Organigram has not yet listed on a more senior exchange?It seems to me this would expand its attractiveness to a wider shareholder base and perhaps given its size from a market cap perspective allow the company to be included in indexes.Do they have any plans to apply to either Nasdaq and/ or TSX exchange listings?
Q: Could you give me your opinion on this micro cap as far as any near term catalysts,earnings growth,cash burn rate and management,any info would be appreciated....thanks
Q: This company has a a rocket trajectory to the upside over the past few months. I currently have a 1.5 % positinm thanks to a 156% gain. Do I sell, or would you let it ride?
I don’t need any cash for the medium
Thanks
Karim
I don’t need any cash for the medium
Thanks
Karim
Q: would you know anything about this co. a friend is exited about it.its listed both tsx and u.s thank you brian w